Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Sexual Dysfunctions, Psychological 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Metastatic Neuroendocrine Prostate Cancer 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1

Interventions

Bevacizumab 21 Paclitaxel 18 Carboplatin 13 pembrolizumab 11 olaparib 10 liposomal doxorubicin 10 Gemcitabine 9 Cyclophosphamide 9 Specimen Handling 8 Topotecan 7 Magnetic Resonance Spectroscopy 7 fludarabine 6 Fulvestrant 6 Taxes 5 Immunoglobulin G 5 Disulfides 5 palbociclib 4 niraparib 4 mirvetuximab soravtansine 4 Oxaliplatin 4 Nivolumab 4 Biopsy 4 trastuzumab deruxtecan 3 ipatasertib 3 cediranib 3 capivasertib 3 atezolizumab 3 aldesleukin 3 Leucovorin 3 Fluorouracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Gonadotropin-Releasing Hormone × 30 days × Clear all

NCT04931342 2026-06-08

BOUQUET

Hoffmann-La Roche

Phase 2 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡